{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:32Z","timestamp":1786123232828,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Reducing fresh gas flow (FGF) during general anesthesia reduces costs by decreasing the consumption of volatile anesthetics and attenuates their contribution to greenhouse gas pollution of the environment. The sevoflurane FGF recommendations in the Food and Drug Administration package insert relate to concern over potential toxicity from accumulation in the breathing circuit of compound A, a by-product of the reaction of the volatile agent with legacy carbon dioxide absorbents containing strong alkali such as sodium or potassium hydroxide. Newer, nonreactive absorbents do not produce compound A, making such restrictions moot. We evaluated 4 hypotheses for sevoflurane comparing intervals before and after converting from a legacy absorbent (soda lime) to a nonreactive absorbent (Litholyme\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ): (1) intraoperative FGF would be reduced; (2) sevoflurane consumption per minute of volatile agent administration would be reduced; (3) cost savings due to reduced sevoflurane consumption would (modestly) exceed the incremental cost of the premium absorbent; and (4) residual wastage in discarded sevoflurane bottles would be &lt;1%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Inspired carbon dioxide (PICO\n                      <jats:sub>2<\/jats:sub>\n                      ), expired carbon dioxide, oxygen, air, and nitrous oxide FGF, inspired volatile agent concentrations (Fi\n                      <jats:sub>Agent<\/jats:sub>\n                      ), and liquid volatile agent consumption were extracted from our anesthesia information management system for 8 4 week intervals before and after the absorbent conversion. Anesthesia providers were notified by e-mail and announcements at Grand Rounds about the impending change and were encouraged to reduce their average intraoperative sevoflurane FGF to 1.25 L\/min. Personalized e-mail reports were sent every 4 weeks throughout the study period regarding the average intraoperative FGF (i.e., from surgery begin to surgery end) for each agent. Batch means methods were used to compare FGF, volatile agent consumption, net cost savings, and residual sevoflurane left in bottles to be discarded in the trash after filling vaporizers. The time from reaching a PICO\n                      <jats:sub>2<\/jats:sub>\n                      = 3 mm Hg for 3 minutes until agent exhaustion (PICO\n                      <jats:sub>2<\/jats:sub>\n                      = 5 mm Hg for 5 minutes) was evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      = 20,235 cases were analyzed (80.2% sevoflurane, 15.1% desflurane, and 4.7% isoflurane). Intraoperative FGF was reduced for cases in which sevoflurane was administered by 435 mL\/min (95% confidence interval [CI], 391 to 479 mL\/min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 10\n                      <jats:sup>\u22125<\/jats:sup>\n                      ). Hypothesis 1 was accepted. Sevoflurane consumption per minute of administration decreased by 0.039 mL\/min (95% CI, 0.029 to 0.049 mL\/min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 10\n                      <jats:sup>\u22125<\/jats:sup>\n                      ) after the change to the nonreactive absorbent. Hypothesis 2 was accepted. The difference in mean cost for the sum of the sevoflurane and absorbent purchases for each of the 10 4-week intervals before and after the absorbent switch was \u2212$293 per 4-week interval (95% CI, \u2212$2853 to $2266;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.81). Hypothesis 3 was rejected. The average amount of residual sevoflurane per bottle was 0.67 \u00b1 0.06 mL (95% CI, 0.54 to 0.81 mL per bottle;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 10\n                      <jats:sup>\u22125<\/jats:sup>\n                      vs 2.5 mL). Hypothesis 4 was accepted. Once the PICO\n                      <jats:sub>2<\/jats:sub>\n                      reached 3 mm Hg for at least 3 consecutive minutes, the absorbent became exhausted within 95 minutes in most (i.e., &gt;50%) canisters\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      We showed that an anesthesia department can transition to a premium, nonreactive carbon dioxide absorbent in a manner that is at least cost neutral by reducing FGF below the lower flow limits recommended in the sevoflurane package insert. This was achieved, in part, by electronically monitoring PICO\n                      <jats:sub>2<\/jats:sub>\n                      , automatically notifying the anesthesia technicians when to change the absorbent, and by providing personalized feedback via e-mail to the anesthesia providers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000001124","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T08:05:46Z","timestamp":1452067546000},"page":"996-1006","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Economic and Environmental Considerations During Low Fresh Gas Flow Volatile Agent Administration After Change to a Nonreactive Carbon Dioxide Absorbent"],"prefix":"10.1213","volume":"122","author":[{"given":"Richard H.","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Dexter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj K.","family":"Agarwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gratch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20250810","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/ALN.0b013e3182829de0","article-title":"Reducing wastage of inhalation anesthetics using real-time decision support to notify of excessive fresh gas flow.","volume":"118","author":"Nair","year":"2013","journal-title":"Anesthesiology"},{"key":"R2-10-20250810","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1213\/ANE.0b013e31824f6940","article-title":"Life cycle greenhouse gas emissions of anesthetic drugs.","volume":"114","author":"Sherman","year":"2012","journal-title":"Anesth Analg"},{"key":"R3-10-20250810","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1213\/ANE.0b013e31824ddfef","article-title":"Workplace sustainability: the cradle to grave view of what we do.","volume":"114","author":"McGain","year":"2012","journal-title":"Anesth Analg"},{"key":"R4-10-20250810","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0310057X1103900318","article-title":"Observational study of anaesthetists fresh gas flow rates during anaesthesia with desflurane, isoflurane and sevoflurane.","volume":"39","author":"Dexter","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"R5-10-20250810","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1213\/ANE.0000000000000677","article-title":"Influencing anesthesia provider behavior using anesthesia information management system data for near real-time alerts and post hoc reports.","volume":"121","author":"Epstein","year":"2015","journal-title":"Anesth Analg"},{"key":"R6-10-20250810","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/bja\/74.6.667","article-title":"Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime.","volume":"74","author":"Bito","year":"1995","journal-title":"Br J Anaesth"},{"key":"R8-10-20250810","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00000542-199212000-00017","article-title":"Reaction of sevoflurane and its degradation products with soda lime: toxicity of the byproducts.","volume":"77","author":"Morio","year":"1992","journal-title":"Anesthesiology"},{"key":"R9-10-20250810","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/00000542-199512000-00013","article-title":"Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIFE), in Sprague-Dawley rats.","volume":"83","author":"Keller","year":"1995","journal-title":"Anesthesiology"},{"key":"R10-10-20250810","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/00000542-199212000-00003","article-title":"Quantification of the degradation products of sevoflurane in two CO2 absorbents during low-flow anesthesia in surgical patients.","volume":"77","author":"Frink","year":"1992","journal-title":"Anesthesiology"},{"key":"R11-10-20250810","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00000542-199401000-00014","article-title":"Closed-circuit anesthesia with sevoflurane in humans. Effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit.","volume":"80","author":"Bito","year":"1994","journal-title":"Anesthesiology"},{"key":"R12-10-20250810","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00000542-199706000-00003","article-title":"Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia.","volume":"86","author":"Bito","year":"1997","journal-title":"Anesthesiology"},{"key":"R13-10-20250810","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/00000542-199706000-00004","article-title":"Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity.","volume":"86","author":"Kharasch","year":"1997","journal-title":"Anesthesiology"},{"key":"R14-10-20250810","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199808000-00006","article-title":"Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity.","volume":"89","author":"Higuchi","year":"1998","journal-title":"Anesthesiology"},{"key":"R15-10-20250810","first-page":"1262","article-title":"The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function.","volume":"91","author":"Obata","year":"2000","journal-title":"Anesth Analg"},{"key":"R16-10-20250810","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00000542-200012000-00010","article-title":"Renal responses to low-flow desflurane, sevoflurane, and propofol in patients.","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"R17-10-20250810","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-6576.2006.01187.x","article-title":"Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.","volume":"51","author":"Keijzer","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R18-10-20250810","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2044.2004.03704.x","article-title":"Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.","volume":"59","author":"Struys","year":"2004","journal-title":"Anaesthesia"},{"key":"R19-10-20250810","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/00000542-199810000-00018","article-title":"Mechanistic aspects of carbon monoxide formation from volatile anesthetics.","volume":"89","author":"Baxter","year":"1998","journal-title":"Anesthesiology"},{"key":"R20-10-20250810","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1213\/ANE.0b013e3182a08d90","article-title":"Automated, real-time fresh gas flow recommendations alter isoflurane consumption during the maintenance phase of anesthesia in a simulator-based study.","volume":"117","author":"Luria","year":"2013","journal-title":"Anesth Analg"},{"key":"R21-10-20250810","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF03008331","article-title":"The cost of anaesthetic vapours.","volume":"39","author":"Dion","year":"1992","journal-title":"Can J Anaesth"},{"key":"R22-10-20250810","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1213\/ANE.0b013e318227518f","article-title":"Analysis of variance of communication latencies in anesthesia: comparing means of multiple log-normal distributions.","volume":"113","author":"Ledolter","year":"2011","journal-title":"Anesth Analg"},{"key":"R23-10-20250810","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00000542-200506000-00026","article-title":"Estimating the incidence of prolonged turnover times and delays by time of day.","volume":"102","author":"Dexter","year":"2005","journal-title":"Anesthesiology"},{"key":"R24-10-20250810","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1213\/ANE.0b013e3182a44d86","article-title":"Increased mean time from end of surgery to operating room exit in a historical cohort of cases with prolonged time to extubation.","volume":"117","author":"Dexter","year":"2013","journal-title":"Anesth Analg"},{"key":"R25-10-20250810","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1213\/01.ANE.0000154536.34258.A8","article-title":"Validation of statistical methods to compare cancellation rates on the day of surgery.","volume":"101","author":"Dexter","year":"2005","journal-title":"Anesth Analg"},{"key":"R26-10-20250810","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jclinane.2014.05.005","article-title":"High-quality operating room management research.","volume":"26","author":"Dexter","year":"2014","journal-title":"J Clin Anesth"},{"key":"R27-10-20250810","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jclinane.2014.02.008","article-title":"Elective change of surgeon during the OR day has an operationally negligible impact on turnover time.","volume":"26","author":"Austin","year":"2014","journal-title":"J Clin Anesth"},{"key":"R28-10-20250810","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1213\/ANE.0b013e31824d6150","article-title":"Medical intelligence article: assessing the impact on global climate from general anesthetic gases.","volume":"114","author":"Sulbaek Andersen","year":"2012","journal-title":"Anesth Analg"},{"key":"R29-10-20250810","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/bja\/aeq259","article-title":"Inhalation anaesthetics and climate change.","volume":"105","author":"Sulbaek Andersen","year":"2010","journal-title":"Br J Anaesth"},{"key":"R30-10-20250810","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ngeo1022","article-title":"Update on CO2 emissions.","volume":"3","author":"Friedlingstein","year":"2010","journal-title":"Nat Geosci"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201604000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:24Z","timestamp":1786112844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201604000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001124","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}